Related Experiment Video
Updated: Nov 12, 2025

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Dual regulation of TxNIP by ChREBP and FoxO1 in liver
Benedicte Noblet1, Fadila Benhamed1, InSug O-Sullivan2,3
1Université de Paris, Institut Cochin, CNRS, INSERM, 75014 Paris, France.
Abstract:
TxNIP (Thioredoxin-interacting protein) is considered as a potential drug target for type 2 diabetes. Although TxNIP expression is correlated with hyperglycemia and glucotoxicity in pancreatic β cells, its regulation in liver cells has been less investigated. In the current study, we aim at providing a better understanding of Txnip regulation in hepatocytes in response to physiological stimuli and in the context of hyperglycemia in db/db mice. We focused on regulatory pathways governed by ChREBP (Carbohydrate Responsive Element Binding Protein) and FoxO1 (Forkhead box protein O1), transcription factors that play central roles in mediating the effects of glucose and fasting on gene expression, respectively. Studies using genetically modified mice reveal that hepatic TxNIP is up-regulated by both ChREBP and FoxO1 in liver cells and that its expression strongly correlates with fasting, suggesting a major role for this protein in the physiological adaptation to nutrient restriction.
Insights
Thioredoxin-interacting protein (TxNIP) regulation in liver cells was investigated. Hepatic TxNIP expression is controlled by ChREBP and FoxO1, correlating with fasting and nutrient restriction.
Area of Science:
- Metabolism and endocrinology
- Molecular biology
- Cellular regulation
Background:
- Thioredoxin-interacting protein (TxNIP) is implicated in type 2 diabetes and linked to hyperglycemia in pancreatic beta cells.
- Hepatic regulation of TxNIP, particularly in response to physiological stimuli and hyperglycemia, remains less understood.
- Transcription factors ChREBP (Carbohydrate Responsive Element Binding Protein) and FoxO1 (Forkhead box protein O1) are key regulators of glucose and fasting responses in gene expression.
Purpose of the Study:
- To elucidate the regulatory mechanisms of Txnip in hepatocytes.
- To investigate Txnip regulation in response to physiological stimuli and hyperglycemia using a mouse model.
- To understand the roles of ChREBP and FoxO1 in hepatic Txnip expression.
Main Methods:
- Utilized genetically modified mice to study Txnip regulation in liver cells.
- Investigated the influence of hyperglycemia in a db/db mouse model.
- Focused on the roles of ChREBP and FoxO1 transcription factors.
Main Results:
- Hepatic TxNIP expression is upregulated by both ChREBP and FoxO1 in liver cells.
- Txnip expression in the liver shows a strong correlation with fasting states.
- Identified TxNIP as a key player in the physiological adaptation to nutrient restriction.
Conclusions:
- Both ChREBP and FoxO1 are critical regulators of hepatic Txnip expression.
- TxNIP plays a significant role in the liver's response to fasting and nutrient restriction.
- Understanding TxNIP regulation in the liver offers insights into metabolic diseases like type 2 diabetes.
Related Concept Videos
Cell Specific Gene Expression
Regulation of Nuclear Protein Sorting
Regulation of the Unfolded Protein Response
Regulation of Metabolism
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps

